Abstract:Abstract Insulin receptor (IR) and hypoxia-inducible factor-1 (HIF-1) master two different intracellular signaling pathways. Both the pathways regulate growth, glycolysis, migration and angiogenesis in cancer. We hypothesized that the IR and HIF-1 pathways are interrelated to each other in pancreatic cancer cells. To test this hypothesis, we designated 45 athymic mice to six tumor-carrying groups (6-7 mice per group) and an intact control group (n=5). All tumor carriers were subject to one of the following conditions: (i) injection of beta-cell-toxin streptozotosin (SZ) before cancer induction, (ii) daily injection of insulin after cancer induction, and (iii) no treatment other than cancer induction. In a 12-week experiment, wild-type MiaPaCa2 human pancreatic cancer cells and HIF-1-null si-MiaPaCa2 cells were implanted orthotopically. When wild-type cells were used, the resulting groups were mice(wt-sz), mice(wt-in), and mice(wt-un). When si-MiaPaCa2 cells were used, the resulting groups were mice(si-sz), mice(si-in), and mice(si-un). In the end of the experiment, insulin was determined in pancreas and plasma by radioimmunoassay. Tumor viability was assessed by histology and Western blots. We found that pancreatic insulin was decreased in all tumor carriers except mice(wt-in), which suggests that tumor carriage per se impaired pancreatic beta-cells. When plasma insulin was determined, significant decreases were seen in mice(wt-sz) and mice(si-sz). Thus, SZ treatment caused additional damage on pancreatic beta-cells and thereby decreased plasma insulin. When glucose and lactate were determined in the plasma, decreased glucose and increased lactate were seen in four out of six tumor-carrying groups. These changes may be due to an uncontrolled glycolysis in cancer cells (also known as the Warburg effect). When tumors were weighed, the biggest ones came from mice(wt-in). Necrosis was seen in all tumors, but tumors from mice(wt-un) had the least necrosis. It suggests that normal pancreas is the best environment for insulin-HIF-1 cooperation. We performed Western blots to determine IR, hexokinase-II (HK-II, a glycolytic enzyme), and vascular endothelial growth factor (VEGF) in tumor grafts. HK-II and VEGF are known to be regulated by HIF-1. In addition, HK-II and VEGF are also known to be involved in IR-motivated signaling cascades. In the present study, insulin injection in mice(wt-in) and mice(si-in) increased IR expression. However, increased HK-II and VEGF expression were only seen in tumors from mice(wt-in) but not mice(si-in). This suggests that HIF-1 is a prerequisite for insulin to stimulate glycolysis and angiogenesis. Finally, we determined caveolin-1 in tumors. Caveolin-1 is an IR regulator, and caveolin-1 gene is regulated by HIF-1. In this study, we found that wild-type tumors had greater caveolin-1 expression than HIF-1-null tumors. In conclusion, insulin and HIF-1 systems cooperate to give survival advantage to pancreatic cancer cells. HIF-1 expression is a prerequisite for insulin to stimulate pancreatic cancer cells. HIF-1 is also necessary for pancreatic cancer cells to express caveolin-1. Citation Format: Yue Chen, Dapeng Zhang, Lihua Cui, Feng Wang. Insulin and hypoxia-inducible factor-1 cooperate to increase the viability of pancreatic cancer cells. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Innovations in Research and Treatment; May 18-21, 2014; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2015;75(13 Suppl):Abstract nr A35.

Insulin, insulin receptors, and cancer

The Increased Risk of Cancers

Insulin promotes hepatocarcinoma tumorigenesis by up-regulating PKM2 expression

Insulin Upregulates FHOD1 Expression and Promotes the Invasion and Migration of Pancreatic Cancer Ccells Via Insulin Receptor-Dependent EMT Activation

Hyperinsulinemia in Obesity, Inflammation, and Cancer

From hyperinsulinemia to cancer progression: how diminishing glucose storage capacity fuels insulin resistance

Diabetes and cancer relationships.

Insulin resistance in vascular endothelial cells promotes intestinal tumour formation

Insulin Promotes Proliferative Vitality and Invasive Capability of Pancreatic Cancer Cells Via Hypoxia-Inducible Factor 1α Pathway

Insulin - like growth factor type 1 receptor and malignancy:An update

Oncogenic Activity of Insulin in the Development of Non-Small Cell Lung Carcinoma

Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics

Abstract A35: Insulin and Hypoxia-Inducible Factor-1 Cooperate to Increase the Viability of Pancreatic Cancer Cells

Abstract B055: Hyperinsulinemia acts via acinar cell insulin receptors to drive obesity-associated pancreatic cancer initiation

Insulin and Hypoxia-Inducible Factor-1 Cooperate in Pancreatic Cancer Cells to Increase Cell Viability.

The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular

Diabetes and cancer: Epidemiological and biological links

[Interactions of insulin and estrogen in the regulation of cell proliferation and carcinogenesis]

The effect of insulin on the chemosensitivity of cancer cells

Changes in Cells Associated with Insulin Resistance

Intra-Pancreatic Insulin Nourishes Cancer Cells: Do Insulin-Receptor Antagonists Such As PGG and EGCG Play a Role?